This website is part of the ECDC (European Centre for Disease Prevention and Control) network
ECDC logo
Contact Sitemap Links RSS feeds
Font:
Accessibility
 
European Center for Disease Prevention and Control






Go to extranet
   
Skip Navigation Links
Home
About Us
Activities
Health Topics
Publications
Media Centre
Influenza virus characterisation, summary Europe, May-June 2011
Technical reports - 30 Jun 2011
Available as PDF in the following languages:
This document is free of charge.
ABSTRACT

Influenza A(H1N1)pdm, influenza A(H3N2), and influenza B/Victoria/2/87 lineage viruses have been characterised genetically and antigenically.

  • Recently isolated A(H1N1)pdm viruses continue to fall into several genetic groups but all groups show antigenic similarity to the currently recommended vaccine virus A/California/7/2009.
  • A(H3N2) viruses also continue to fall into distinct genetic groups with some viruses showing antigenic difference from the currently used vaccine virus A/Perth/16/2009, but there is no consistent correlation of altered antigenicity with any genetic group.
  • Influenza B viruses of the B/Victoria/2/87 lineage have predominated over those of the B/Yamagata/2/87 lineage. Most of the B/Victoria/2/87 lineage viruses are genetically and antigenically similar to the currently recommended vaccine virus B/Brisbane/60/2008.

 TOP SIX HEALTH TOPICS

 STAY UP TO DATE

 EUROSURVEILLANCE

   Share